Impact Capital Partners LLC Makes New Investment in Chemed Co. (NYSE:CHE)

Impact Capital Partners LLC purchased a new stake in Chemed Co. (NYSE:CHE) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm purchased 743 shares of the company’s stock, valued at approximately $394,000.

A number of other large investors have also made changes to their positions in CHE. UMB Bank n.a. increased its holdings in shares of Chemed by 300.0% in the 4th quarter. UMB Bank n.a. now owns 52 shares of the company’s stock valued at $28,000 after purchasing an additional 39 shares in the last quarter. Trust Co. of Vermont purchased a new position in shares of Chemed in the 4th quarter valued at about $34,000. Tortoise Investment Management LLC increased its holdings in shares of Chemed by 77.3% in the 4th quarter. Tortoise Investment Management LLC now owns 78 shares of the company’s stock valued at $41,000 after purchasing an additional 34 shares in the last quarter. SRS Capital Advisors Inc. increased its holdings in shares of Chemed by 39.2% in the 4th quarter. SRS Capital Advisors Inc. now owns 135 shares of the company’s stock valued at $72,000 after purchasing an additional 38 shares in the last quarter. Finally, Allworth Financial LP increased its holdings in shares of Chemed by 2,057.1% in the 4th quarter. Allworth Financial LP now owns 151 shares of the company’s stock valued at $83,000 after purchasing an additional 144 shares in the last quarter. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Insider Activity at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $593.67, for a total transaction of $1,187,340.00. Following the sale, the chief executive officer now directly owns 102,679 shares of the company’s stock, valued at $60,957,441.93. This trade represents a 1.91 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, VP Brian C. Judkins purchased 145 shares of the firm’s stock in a transaction on Monday, December 30th. The shares were purchased at an average cost of $519.50 per share, for a total transaction of $75,327.50. Following the completion of the purchase, the vice president now directly owns 1,678 shares in the company, valued at $871,721. The trade was a 9.46 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 3.32% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Separately, StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a report on Friday, March 7th.

Chemed Trading Up 0.1 %

Shares of NYSE CHE opened at $590.03 on Friday. The stock has a market cap of $8.64 billion, a price-to-earnings ratio of 29.81, a PEG ratio of 2.15 and a beta of 0.43. Chemed Co. has a 52 week low of $512.12 and a 52 week high of $654.62. The company’s 50-day moving average price is $557.78 and its 200 day moving average price is $564.44.

Chemed Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 14th. Investors of record on Monday, February 24th will be paid a $0.50 dividend. The ex-dividend date is Monday, February 24th. This represents a $2.00 dividend on an annualized basis and a yield of 0.34%. Chemed’s payout ratio is 10.05%.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.